215 related articles for article (PubMed ID: 32630562)
1. Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study.
Cheng CY; Chen CH; Wu MF; Wu MJ; Chen JP; Liu YM; Hou YC; Wang HY
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32630562
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Risk Factors of Posttransplantation Diabetes Mellitus in Living Donor Kidney Transplantation: A Single-Center Retrospective Study in China.
Xu J; Xu L; Wei X; Li X; Cai M
Transplant Proc; 2018 Dec; 50(10):3381-3385. PubMed ID: 30471834
[TBL] [Abstract][Full Text] [Related]
3. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tacrolimus Trough Level in Patients Who Developed Post-transplant Diabetes Mellitus After Kidney Transplantation: A Retrospective Single-Center Study in Saudi Arabia.
Ajabnoor A; Nasser M; Khan N; Habhab W
Transplant Proc; 2020 Dec; 52(10):3160-3167. PubMed ID: 32636070
[TBL] [Abstract][Full Text] [Related]
5. Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression.
Baron PW; Infante S; Peters R; Tilahun J; Weissman J; Delgado L; Kore AH; Beeson WL; de Vera ME
Ann Transplant; 2017 May; 22():309-314. PubMed ID: 28533501
[TBL] [Abstract][Full Text] [Related]
6. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
Choi JY; Kwon OJ
Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation.
Cheng F; Li Q; Wang J; Wang Z; Zeng F; Zhang Y
Saudi Pharm J; 2022 Aug; 30(8):1088-1094. PubMed ID: 36164572
[TBL] [Abstract][Full Text] [Related]
9. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C
Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
[TBL] [Abstract][Full Text] [Related]
11. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.
Bloom RD; Rao V; Weng F; Grossman RA; Cohen D; Mange KC
J Am Soc Nephrol; 2002 May; 13(5):1374-80. PubMed ID: 11961026
[TBL] [Abstract][Full Text] [Related]
12. Development of diabetes mellitus following kidney transplantation: a Canadian experience.
Gourishankar S; Jhangri GS; Tonelli M; Wales LH; Cockfield SM
Am J Transplant; 2004 Nov; 4(11):1876-82. PubMed ID: 15476489
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant diabetes mellitus: incidence, predicting factors and outcomes.
Mizrahi N; Braun M; Ben Gal T; Rosengarten D; Kramer MR; Grossman A
Endocrine; 2020 Aug; 69(2):303-309. PubMed ID: 32418071
[TBL] [Abstract][Full Text] [Related]
14. Serum magnesium, hepatocyte nuclear factor 1β genotype and post-transplant diabetes mellitus: a prospective study.
van der Burgh AC; Moes A; Kieboom BCT; van Gelder T; Zietse R; van Schaik RHN; Hesselink DA; Hoorn EJ
Nephrol Dial Transplant; 2020 Jan; 35(1):176-183. PubMed ID: 31361318
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis.
Oliveras L; Coloma A; Lloberas N; Lino L; Favà A; Manonelles A; Codina S; Couceiro C; Melilli E; Sharif A; Hecking M; Guthoff M; Cruzado JM; Pascual J; Montero N
Transplant Rev (Orlando); 2024 Jul; 38(3):100856. PubMed ID: 38723582
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus after living donor liver transplantation: data from mainland China.
Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
[TBL] [Abstract][Full Text] [Related]
17. Incidence of posttransplantation diabetes mellitus in kidney transplantation: a single-center experience.
Roozbeh J; Mehdizadeh AR; Razmkon A; Malek-Hosseini SA
Transplant Proc; 2005 Sep; 37(7):3095-7. PubMed ID: 16213317
[TBL] [Abstract][Full Text] [Related]
18. The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus.
Prokai A; Fekete A; Pasti K; Rusai K; Banki NF; Reusz G; Szabo AJ
Pediatr Diabetes; 2012 Feb; 13(1):81-91. PubMed ID: 21595806
[TBL] [Abstract][Full Text] [Related]
19. Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study.
Dienemann T; Fujii N; Li Y; Govani S; Kosaraju N; Bloom RD; Feldman HI
Transpl Int; 2016 Sep; 29(9):1017-28. PubMed ID: 27284760
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment and management of post-transplant diabetes mellitus.
Han E; Kim MS; Kim YS; Kang ES
Metabolism; 2016 Oct; 65(10):1559-69. PubMed ID: 27621191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
